Archimedes was founded more than 20 years ago to provide Kaiser Permanente officials with quantitative information on predicted outcomes that could be expected from different clinical and administrative policies and programs. The Archimedes Model proved successful, and in 2007 the Robert Wood Johnson Foundation granted the company $1.6 million to help make the model accessible to other organizations.
Archimedes’ new owners are Symphony Technology Group, a private equity firm and its wholly owned subsidiary, Evidera, an analytics and research firm.
“We are committed to continuing the mission of the original intent of Archimedes and its model of quantitative healthcare,” said Jed Weissberg, MD, senior vice president of hospitals, quality and care delivery excellence at Kaiser Permanente, in a news release. “The buyer, Symphony/Evidera, is a great home to enable the scientists to further their pursuits to enable personalized care for the future of medicine.”
More Articles on the Health IT Market:
Survey: Half of Consumers Want Wearable Health, Fitness Trackers
IMS Health Files Potential Billion-Dollar IPO
North American Health IT Market to Hit $31.3B by 2017
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
